Amicus Therapeutics (FOLD)
(Delayed Data from NSDQ)
$8.99 USD
+0.13 (1.47%)
Updated Nov 4, 2025 03:59 PM ET
After-Market: $9.01 +0.02 (0.22%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth D Momentum F VGM
Fundamental Charts
About Dividend Yield (TTM)
Amicus Therapeutics, Inc.'s dividend yield currently sits at 0%, which is in-line with the Medical - Biomedical and Genetics industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
FOLD 8.99 +0.13(1.47%)
Will FOLD be a Portfolio Killer in November?
Zacks Investment Research is releasing its prediction for FOLD based on the 1-3 month trading system that more than doubles the S&P 500.

Zacks News for FOLD
Earnings Estimates Moving Higher for Amicus Therapeutics (FOLD): Time to Buy?
Does Amicus Therapeutics (FOLD) Have the Potential to Rally 138.21% as Wall Street Analysts Expect?
FOLD: What are Zacks experts saying now?
Zacks Private Portfolio Services
Moderna (MRNA) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Analysts Estimate Amicus Therapeutics (FOLD) to Report a Decline in Earnings: What to Look Out for
Other News for FOLD
Amicus Therapeutics, Inc. 2025 Q3 - Results - Earnings Call Presentation
Amicus Therapeutics: Strong Q3 Performance and Strategic Advancements Justify Buy Rating
Amicus Therapeutics Reports Strong Q3 2025 Results
FOLD December 2026 Options Begin Trading
FOLD forms 1,2,3 Pullback Bullish on November 3